Bone healing of critical-sized nasal defects in rabbits by statins in two different carriers

Clinical Oral Implants Research

Volumn 22, Issue 11, 2011, Pages 1327-1335

  Mukozawa, Aya ^a   Ueki, Koichiro ^a   Marukawa, Kohei ^a   Okabe, Katsuhiko ^a   Moroi, Akinori ^a   Nakagawa, Kiyomasa ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Animal experiments; Biomaterials; Bone substitutes

Indexed keywords

ATELOCOLLAGEN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; DRUG CARRIER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ANIMAL; ARTICLE; BIODEGRADABLE IMPLANT; BONE DEVELOPMENT; BONE DISEASE; BONE REGENERATION; COMPARATIVE STUDY; CONNECTIVE TISSUE; DRUG EFFECT; HYDROGEL; IMMUNOHISTOCHEMISTRY; MALE; NASAL BONE; NOSE DISEASE; OSTEOBLAST; PATHOLOGY; RABBIT; TIME;

ABSORBABLE IMPLANTS; ANIMALS; BONE DISEASES; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; COLLAGEN; CONNECTIVE TISSUE; DRUG CARRIERS; HYDROGEL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; MALE; NASAL BONE; NOSE DISEASES; OSTEOBLASTS; OSTEOGENESIS; RABBITS; SIMVASTATIN; TIME FACTORS;

EID: 80053903872     PISSN: 09057161     EISSN: 16000501     Source Type: Journal    
DOI: 10.1111/j.1600-0501.2010.02135.x     Document Type: Article

References (39)

1. Alam, S., Ueki, K., Marukawa, K., Ohara, T., Hase, T., Takazakura, D. & Nakagawa, K. (2007) Expression of bone morphogenetic protein 2 and fibroblast growth factor 2 during bone regeneration using different implant materials as an onlay bone graft in rabbit mandibles. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 103: 16-26.
2. Alam, S., Ueki, K., Nakagawa, K., Marukawa, K., Hashiba, Y., Yamamoto, E., Sakulsak, N. & Iseki, S. (2009) Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 107: 22-29.
3. Bellows, C.G., Aubin, J.E., Heersche, J.N. & Antosz, M.E. (1986) Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcified Tissue International 38: 143-154.
4. Chen, P.Y., Sun, J.S., Tsuang, Y.H., Chen, M.H., Weng, P.W. & Lin, F.H. (2010) Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Eek/BMP-2 signaling pathway. Nutrition Research 30: 191-199.
5. Fukunaka, Y., Iwanaga, K., Morimoto, K., Kakemi, M. & Tabata, Y. (2002) Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. Journal of Controlled Release 80: 333-343.
6. Henwood, J.M. & Heel, R.C. (1988) Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidemia. Drugs 36: 429-454.
7. Hunninghake, D.B. (1998) Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy. The American Journal of Medicine 104: 9s-13s.
8. Inoda, H., Yamamoto, G. & Hattory, T. (2004) Histological investigation of osteoinductive properties of the rh-BMP-2 in rat calvarial bone defect model. Journal of Cranio-Maxillofacial Surgery 32: 365-369.
9. Kimura, Y. & Tabata, Y. (2010) Controlled release of stromal cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. Journal of Biomaterials Science. Polymer Edition 21: 37-51.
10. Kishida, Y., Naito, A., Iwado, S., Terahara, A. & Tsujita, Y. (1991) Research and development of pravastatin. Yakugaku Zasshi 111: 469-487.
11. Koide, M., Osaki, K., Konish, i J., Oyamada, K., Katakura, T., Takahashi, A. & Yoshizato, K. (1993) A new type of biomaterial for artificial skin: dehydrothermally cross-linked composites of fibrillar and denatured collagens. Journal of Biomedical Materials Research 27: 79-87.
12. Konishi, M., Tabata, Y., Kariya, M., Suzuki, A., Mandai, M., Nanbu, K., Takakura, K. & Fujii, S. (2003) In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. Journal of Controlled Release 92: 301-313.
13. Lee, Y., Schmid, M.J., Marx, D.B., Beatty, M.W., Cullen, D.M., Collons, M.E. & Reinhardt, R.A. (2008) The effect of local simvastatin delivery strategies on mandibular bone formation in vivo. Biomaterials 29: 1940-1949.
14. Maeda, T., Matsunuma, A., Kawane, T. & Horiuchi, N. (2001) Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochemical and Biophysical Research Communications 280: 874-877.
15. Maniatopoulos, C., Melcher, A.H. & Sodek, J. (1988) Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell and Tissue Research 254: 317-330.
16. Marie, P.J. (1995) Human endosteal osteoblastic cells: relationship with bone formation. Calcified Tissue International 56: 13-16.
17. Marukawa, K., Ueki, K., Alam, S., Shimada, M., Nakagawa, K. & Yamamoto, E. (2006) Expression of bone morphogenetic protein-2 and proliferating cell nuclear antigen during distraction osteogenesis in the mandible in rabbits. British Journal of Oral and Maxillofacial Surgery 44: 141-145.
18. Marukawa, K., Ueki, K., Okabe, K., Nakagawa, K. & Yamamoto, E. (2010) Use of self-setting α-tricalcium phosphate for maxillary sinus augmentation in rabbit. Clinical Oral Implants Research 29, doi: DOI: 10.1111/j.1600-0501.2010.02023.x.
19. Matsui, R. (2008) Development of TERUDERMIS, collagen-based artificial dermis and TERUPULUG, collagen-based material for extraction sockets. Journal of Japanese 6: 9-20.
20. Matsumoto, G., Kushibiki, T., Kinoshita, Y., Lee, U., Omi, Y., Kubota, E. & Tabata, Y. (2006) Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma. Cancer Gene Therapy 13: 479-489.
21. McFarlane, S.I., Muniyappa, R., Francisco, R. & Sowers, J.R. (2002) Pleiotropic effects of statins: lipid reduction and beyond. The Journal of Clinical Endocrinology and Metabolism 87: 1451-1458.
22. Montagnani, A., Gonnelli, S., Cepollaro, C., Pacini, S., Campagna, M.S., Framci, M.B., Pacini, S. & Gennari, C. (2003) Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1 year longitudinal study. Bone 32: 427-433.
23. Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M. & Gutierrez, G. (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286: 1946-1949.
24. Nakamura, M., Jo, J., Tabata, Y. & Ishikawa, O. (2008) Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model. The American Journal of Pathology 172: 650-658.
25. Ohnaka, K., Shimoda, S., Nawata, H., Shimokawa, H., Kaibuchi, K., Iwamoto, Y. & Takayanagi, R. (2001) Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochemical and Biophysical Research Communications 287: 337-342.
26. Ozeki, M., Ishii, T., Hirano, Y. & Tabata, Y. (2001) Controlled release of hepatocyte growth factor based on hydrogel biodegradation. Journal of Drug Targeting 9: 461-471.
27. Rogers, M.J. (2000) Statins: lower lipid and better bones. Nature Medicine 6: 21-23.
28. Si, X., Jin, Y., Yang, L., Tipoe, G.L. & White, F.H. (1997) Expression of BMP-2 and TGF-beta 1 mRNA during healing of the rabbit mandible. European Journal of Oral Science 105: 325-330.
29. Stein, D., Lee, Y., Schmid, M.J., Killpack, B., Genrich, M.A., Narayana, N., Marx, D.B., Cullen, D.M. & Reinhardt, R.A. (2005) Local simvastatin effected on mandibular bone growth and inflammation. Journal of Periodontology 76: 1861-1870.
30. Tabata, Y., Hijikata, S. & Ikada, Y. (1994) Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. Journal of Controlled Release 31: 189-199.
31. Tanigo, T., Takaika, R. & Tabata, Y. (2010) Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration. Journal of Controlled Release 143: 201-206.
32. Todd, P.A. & Goa, K.L. (1990) Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolemia. Drugs 40: 583-587.
33. Ueki, K., Takazakura, D., Marukawa, K., Shimada, M., Nakagawa, K., Takatsuka, S. & Yamamoto, E. (2003) The use of polylactic acid/polyglycolic acid copolymer and gelatin sponge complex containing human recombinant bone morphogenetic protein-2 following condylectomy in rabbits. Journal of Cranio-Maxillofacial Surgery 31: 107-114.
34. Uludag, H. (1998) Osteoinductive alternatives to bone grafts. Current Opinion in Orthopaedics 9: 31-37.
35. Uzzan, B., Cohen, R., Nicolas, P., Cucherat, M. & Perret, G.Y. (2007) Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 40: 1581-1587.
36. Wong, R.W. & Rabie, A.B. (2005) Histological and ultrastructural study on statin graft in rabbit skulls. Journal of Oral and Maxillofacial Surgery 63: 1515-1521.
37. Wozeny, J.M., Rosen, V., Celestre, A.J., Mitsok, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M. & Wang, E.A. (1988) Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534.
38. Yamamoto, M., Tabata, Y., Hong, L., Miyamoto, S., Kikuchi, H. & Ikada, Y. (2000) Bone regeneration by transforming growth factor β1 released from a biodegradable hydrogel. Journal of Controlled Release 64: 133-142.
39. Yamamoto, M., Takahashi, Y. & Tabata, Y. (2003) Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24: 4375-4383.